Lippoldt Darin — SEC Form 4 filings
SEC reporting owner CIK 1504783. 16 Form 4 filings on record with FilingPulse; latest filed 2026-09-15.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2024-01-24 to 2026-09-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 12 filings — 53,021 shares, $8,252,662 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 50.
- Largest priced transaction: sale of 10,000 shares @ $179.60 ($1,796,014) in NEUROCRINE BIOSCIENCES INC, filed 2026-07-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | Chief Legal Officer | 16 | — | 16 legs · 53,021 sh · $8,252,662 | 50 |
Form 4 filings — Lippoldt Darin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/award (A): 4,483 @ $0 · Tax withholding (F): 2,419 @ $156.22 | EDGAR |
| 2026-07-13 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 10,000 @ $81.49 · Sale (S): 10,000 @ $179.60 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 200 @ $81.49 · Sale (S): 200 @ $169.56 · Option exercise (M): 8,110 @ $81.49 · Sale (S): 8,110 @ $170.03 · Option exercise (M): 1,690 @ $81.49 · Sale (S): 1,690 @ $170.81 · +3 more | EDGAR |
| 2026-02-17 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,792 @ $0 · Tax withholding (F): 967 @ $123.10 · Option exercise (M): 2,017 @ $0 · Tax withholding (F): 1,089 @ $124.12 · Option exercise (M): 2,083 @ $0 · Tax withholding (F): 1,124 @ $124.12 · +8 more | EDGAR |
| 2026-02-03 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,373 @ $0 · Tax withholding (F): 1,335 @ $136.06 · Option exercise (M): 2,373 (derivative) @ $0 | EDGAR |
| 2026-01-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 3,349 @ $35.99 · Option exercise (M): 3,349 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 4,376 @ $43.24 · Sale (S): 4,376 @ $159.65 · Option exercise (M): 4,376 (derivative) @ $0 | EDGAR |
| 2025-02-14 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Gift (G): 190 @ $0 · Option exercise (M): 2,083 @ $0 · Sale (S): 1,098 @ $116.76 · Option exercise (M): 2,017 @ $0 · Sale (S): 1,086 @ $116.75 · Grant/award (A): 38,252 (derivative) @ $0 · +3 more | EDGAR |
| 2025-02-12 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 1,727 @ $0 · Sale (S): 911 @ $118.25 · Option exercise (M): 1,727 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,373 @ $0 · Sale (S): 1,250 @ $152.91 · Option exercise (M): 2,373 (derivative) @ $0 | EDGAR |
| 2024-08-05 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 2,996 @ $79.02 · Sale (S): 2,996 @ $154.01 · Option exercise (M): 2,996 (derivative) @ $0 | EDGAR |
| 2024-07-18 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 7,004 @ $79.02 · Sale (S): 7,004 @ $150.00 · Option exercise (M): 7,004 (derivative) @ $0 | EDGAR |
| 2024-02-15 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,098 @ $132.99 · Grant/award (A): 40,552 (derivative) @ $0 · Grant/award (A): 8,070 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,041 @ $142.17 · Sale (S): 911 @ $134.24 | EDGAR |
| 2024-02-02 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale (S): 1,250 @ $140.65 | EDGAR |
| 2024-01-24 | 4 | NEUROCRINE BIOSCIENCES INC (NBIX) | Option exercise (M): 10,000 @ $79.02 · Sale (S): 10,000 @ $139.86 · Option exercise (M): 10,000 (derivative) @ $79.02 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1504783 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →